Note: Revenues for privately held companies are statistical evaluations.
Research & Diagnostic Systems's annual revenues are $100-$500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Surgical & Medical Instrument Manufacturing industry.
Note: Research & Diagnostic Systems's revenues are gauged from an analysis of company filings.
Research & Diagnostic Systems's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Research & Diagnostic Systems Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that Research & Diagnostic Systems is developing and marketing.
Research & Diagnostic Systems doesn't have any recent trademark applications, indicating Research & Diagnostic Systems is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
MYCOPROBE Detection kit for scientific, research, and medical research use primarily consisting of reagents for use in in-vitro biochemistry, cell biology, and microbiology
CYTOPRIME IMMUNOASSAY KITS FOR RESEARCH LABORATORY USE
QUANTIGLO in vitro diagnostic immunoassay kits for research laboratory use
Determine whether Research & Diagnostic Systems grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Research & Diagnostic Systems is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Research & Diagnostic Systems's Largest Competitors
A competitive analysis shows these companies are in the same general field as Research & Diagnostic Systems, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Research & Diagnostic Systems.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Research & Diagnostic Systems's Fastest Growing Competitors
These companies are in the same general field as Research & Diagnostic Systems and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.